Aliceblue ANT
Aliceblue ANTInstall and trade smarter everywhere
S

Sagility Ltd

Complete IPO details, including price band, financials, subscription status, and key insights.

Participate in the Sagility Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.

IPO Snapshot

Key metrics and details at a glance.

Price Band

₹30

Per Share

Lot Size

500 Shares

Minimum Investment

₹15,000

Issue Size

₹2,106.6 Cr

Face Value

₹10

Per Share

IPO Type

Book Building

Retail Quota

10%

QIB Quota

75%

NII Quota

15%

IPO Timeline

Important dates for your applying strategy.

IPO Opens5 Nov
IPO Closes7 Nov
Basis of Allotment8 Nov
Refund Initiation8 Nov
Shares Credited11 Nov
Listing Date12 Nov
IPO Process Completed

Subscription Status

Live demand across investor categories.

Track real-time subscription levels:

*Real-time data subject to exchange updates

Qualified Institutional Buyers (QIB)3.52x
Non-Institutional Investors (NII)1.93x
Retail Individual Investors (RII)4.16x
Overall Subscription3.20x

Sagility Ltd

Business model, operations, and market positioning.

Promoter Holding (Pre-Issue)

100%

Promoter Holding (Post-Issue)

85%

Issue Type

Book Building

ISIN

INE0W2G01015

About the Company

Sagility India Limited provides technology-enabled business solutions and services to clients in the U.S. healthcare industry. The Company is a pure-play healthcare focused services provider, and its clients include Payers (U.S. health insurance companies, which finance and reimburse the cost of health services) and Providers (primarily hospitals, physicians, and diagnostic and medical devices companies). its services to Payers cater to various aspects of their operations including (i) core benefits administration functions such as claims management, enrolment, benefits plan building, and premium billing, and (ii) clinical functions such as utilization management, care management, and population health management. Its services to Providers include revenue cycle management functions.

Industry Overview

Healthcare expenditure in the U.S. has grown at a CAGR of 5.0% from 2014 to 2023 and amounted to US$4.7 trillion (Rs.389.6 trillion) in 2023, and further is anticipated to grow at a CAGR of 5.5%, reaching US$6.1 trillion (Rs.509.8 trillion) by 2028. The US healthcare market comprises of two primary entities with respect to care financing and care delivery - healthcare payers and healthcare providers. Healthcare payers are entities that pay for or reimburse healthcare services for insured members through health insurance plans. Healthcare providers are individuals or healthcare facilities that are licensed to deliver care services or aid in care delivery such as doctors, clinics, hospitals, labs, and durable medical equipment providers. Healthcare operations spend by such Payers and Providers in the US was valued at approximately US$201.1 billion (Rs.16.8 trillion) in 2023. This spend is expected to reach approximately US$258.9 billion (Rs.21.6 trillion) in 2028, driven by the rise in the aging population, increasing prevalence of chronic diseases, and various governmental initiatives aimed at enhancing healthcare services, among other factors.

Company History

Sagility India Limited was originally incorporated as `Berkmeer India Private Limited' as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation dated July 28, 2021, issued by the Registrar of Companies, Karnataka at Bengaluru. Subsequently, pursuant to a resolution passed by its Shareholders at the EGM held on August 25, 2022 the name of the Company was changed to `Sagility India Private Limited' and a fresh certificate of incorporation was issued by the Registrar of Companies, Karnataka at Bengaluru on September 13, 2022. Subsequently, the Company was converted from a private limited company to a public limited company, pursuant to a special resolution passed by its Shareholders at the EGM held on May 21, 2024 and the name of the Company was changed to `Sagility India Limited', and a fresh certificate of incorporation was issued to the Company by the RoC, on June 20, 2024.

Products & Services

  • The Company is a pure-play healthcare focused services provider.

Growth Strategy

  • Strengthen its relationships with existing clients, expand its offerings and increase its share of their wallets.
  • Establish new client relationships across categories.
  • Enhance its portfolio of technology tools and platforms.
  • Pursue strategic acquisitions and collaborations.

Customer Base

Clients in the U.S. healthcare industry.

Financial Performance

Revenue, profit after tax and total assets across the last 3 reported financial years.

Consolidated figures
Financial Performance Categories

Revenue

+51.3%vs FY24

Amount in ₹ crore

4,754
5,570
7,193
FY24FY25FY26

Profit After Tax (PAT)

+305%vs FY24

Amount in ₹ crore

228
539
925
FY24FY25FY26

Total Assets

+12.8%vs FY24

Amount in ₹ crore

11,225
11,119
12,663
FY24FY25FY26

Figures in ₹ crore, on a consolidated basis, as reported for FY24 to FY26.

Objects of the Issue

How the company plans to utilize IPO proceeds.

Use of Proceeds

The funds raised through this IPO will be used for:

Initial public offering of 702,199,262 equity shares of face value of Rs. 10 each ("Equity Shares") of Sagility India Limited (The "Company" or the "Issuer") for cash at a price of Rs. 30^ per equity share including a share premium of Rs. 20 per equity share (the "Offer Price") aggregating to Rs. 2106.40* crores (the "Offer"). The offer comprises of an offer for sale of 702,199,262 equity shares of face value of Rs. 10 each (the "Offered Shares") aggregating to Rs. 2106.40* crores (the "Offer for Sale" or the "Offer"), by sagility B.V. the offer will constitute 15.00 % of the post-offer paid-up equity share capital of the company. The offer includes a reservation of 1,900,000 equity shares of face value of Rs. 10 each, aggregating to Rs. 5.32 crores (constituting 0.27% of the post-offer paid-up equity share capital), for subscription by eligible employees ("Employee Reservation Portion"). The offer less the employee reservation portion is hereinafter referred to as "Net Offer". The offer and net offer shall constitute 15.00% and 14.96%, of the post-offer paid-up equity share capital of the company, respectively. ^Subject to finalisation of basis of allotment *A discount of Rs. 2 per equity share was offered to eligible employees bidding in the employees reservation portion.

*Subject to approvals and market conditions.

Strengths & Risks

Key competitive advantages and factors to consider before investing.

Strengths and Risk Factors
  • Leadership position in the large and resilient U.S. Payer and Provider solutions market.
  • Domain expertise in healthcare operations, with end-to-end service offerings to Payers and Providers.
  • Suite of scalable, technology-enabled services and solutions, supported by proprietary tools and platforms.
  • Deep, long-term, expanding client relationships across healthcare Payers and Providers.
  • Multi-shore, scalable and flexible delivery model with certified data protection and service standards.
  • The healthcare services industry is highly competitive and if the company is unable to compete effectively, it may adversely affect its business, financial condition and results of operations.
  • The company's business is solely focused on the U.S. healthcare industry and may be adversely affected by factors affecting the U.S. healthcare industry, including a decline in the growth of the U.S. healthcare industry, reduction in outsourcing and other trends.
  • The company has, in the 12 months preceding the date of this Red Herring Prospectus, issued Equity Shares at a price which may be significantly lower than the Offer Price.
  • Goodwill and other intangible assets are its largest assets. Any impairment to the company goodwill or other intangible assets may adversely affect its reputation and financial condition.
  • One of its Independent Directors has received summons in relation to an ongoing investigation by SEBI of Linde India Limited and the matter is currently pending.

Frequently Asked Questions

01

What is the minimum investment required to apply for this IPO?

The minimum investment depends on the lot size and the upper price band of the issue. Investors must apply for at least one lot, and the total investment amount is calculated by multiplying the lot size by the upper price band.
02

How is IPO allotment decided?

IPO allotment is determined based on demand and SEBI guidelines. If the IPO is oversubscribed in the retail category, allotment is typically done through a computerized lottery system to ensure fair distribution among eligible applicants.
03

When will I know if shares are allotted to me?

Allotment status is usually finalized a few days after the IPO closes. Once finalized, shares are either credited to your Demat account (if allotted) or the blocked funds are released back to your bank account.
04

Can I modify or cancel my IPO application?

Yes, you can modify or cancel your IPO application anytime before the IPO closing date. Changes can be made through your Alice Blue account, subject to exchange cut-off timings.
05

What happens if the IPO is oversubscribed?

If the IPO receives more applications than the number of shares available, it is considered oversubscribed. In such cases, allotment in the retail category is done on a proportionate or lottery basis, and not all applicants may receive shares.